Search alternatives:
significance b » significance _ (Expand Search), significance set (Expand Search), significant _ (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), step decrease (Expand Search)
b decrease » a decrease (Expand Search), b1 decreased (Expand Search), ob decreased (Expand Search)
_ decrease » _ decreased (Expand Search), _ decreasing (Expand Search)
significance b » significance _ (Expand Search), significance set (Expand Search), significant _ (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), step decrease (Expand Search)
b decrease » a decrease (Expand Search), b1 decreased (Expand Search), ob decreased (Expand Search)
_ decrease » _ decreased (Expand Search), _ decreasing (Expand Search)
-
1
-
2
-
3
-
4
-
5
Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration.
Published 2025“…<p><b>(A)</b> A significant decrease in the proliferative clonal capacity of U87MG colonies was observed with 70ΜM and 100ΜM SHG-44 treatment. …”
-
6
-
7
-
8
-
9
-
10
-
11
Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations.
Published 2025“…<b>(D)</b> Similarly, U251MG cells showed significantly decreased clonogenic potential upon 100ΜM SHG-44 treatment when compared to 100ΜM cis-platin and the untreated control. …”
-
12
-
13
Tissue, days post-infection (dpi) and the top 10 most significant genes with increased and decreased expression with valid gene symbols for the response contrasts.
Published 2025“…<p>Tissue, days post-infection (dpi) and the top 10 most significant genes with increased and decreased expression with valid gene symbols for the response contrasts.…”
-
14
B2 decreases glycolytic intermediates in cells.
Published 2025“…The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”
-
15
Inotodiol decreases clone formation in HCC cells.
Published 2025“…Chemicals and chemotherapeutic agents have been experiencing problems such as side effects and drug resistance in the treatment of HCC, which cannot meet the needs of clinical treatment. …”
-
16
The table shows the significant and non-significant altered group with different parameters.
Published 2025Subjects: -
17
-
18
-
19
-
20